LOGC — ContextLogic Holdings Share News
0.000.00%
Last trade - 00:00Brief: U.S. EPA Orders E-Commerce Platform Wish To Stop Selling Illegal Disinfectants- Statement
Brief: Contextlogic To Join The Russell 3000 Index
GameStop surges for second day as cost to borrow spikes
GameStop set for second straight day of gains
LogicBio Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: LogicBio Therapeutics Reports First Quarter 2022 Financial Results
LogicBio surges as FDA lifts hold on metabolic disorder therapy trial
Brief: LogicBio Therapeutics Announces FDA Lifts Clinical Hold On SUNRISE Trial In Pediatric Patients With Methylmalonic Acidemia
Brief: Wish Reports First-Quarter 2022 Financial Results
ContextLogic Inc expected to post a loss of 14 cents a share - Earnings Preview
LogicBio Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Logicbio Therapeutics Reports Full Year 2021 Financial Results
LogicBio Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
ContextLogic down after lower Q4 revenue
ContextLogic Inc reports results for the quarter ended in December - Earnings Summary
Brief: Contextlogic Inc Says Co's Board Of Directors Approved A Restructuring Plan
Brief: Wish Reports Fourth Quarter And Fiscal Year 2021 Financial Results
ContextLogic Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Arix Bioscience PLC Had Previously Reported A Stake Of 9.25% In LogicBio Therapeutics, Inc. As Of November 9, 2020